Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06299540
What this trial is testing

Benefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Janssen Cilag S.A.S. 180
Not applicableStudy completedNCT03903874
What this trial is testing

Testing Scalable, IVR-supported Cancer Prevention Interventions in the Rural Alabama Black Belt

Who this might be right for
Physical Activity
University of Alabama at Birmingham 245
Not applicableLooking for participantsNCT05622344
What this trial is testing

StableEyes With Active Neurofeedback

Who this might be right for
Vestibular DisorderVestibular SchwannomaSpace Motion Sickness+1 more
Johns Hopkins University 48
Not applicableStudy completedNCT01462864
What this trial is testing

Development of a Structured Education Programme for Women With Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary Syndrome
University of Leicester 162
Early research (Phase 1)Looking for participantsNCT07416552
What this trial is testing

Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal Cancer
Hoffmann-La Roche 180
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06281847
What this trial is testing

An Adaptive Open-label Multicentre Phase 1/2 Trial, to Determine the Recommended Phase 2 Dose of CCTx-001, and to Assess Safety, Tolerability, and Clinical Activity in Patients With Relapsed/Refractory Acute Myeloid Leukaemia

Who this might be right for
Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia Refractory
Advesya SAS 143
Not applicableStudy completedNCT04837248
What this trial is testing

Design and Evaluation of the Effects of a Physical Therapy Program With Digital Support in Patients With Breast Cancer

Who this might be right for
Breast Cancer
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 92
Early research (Phase 1)Study completedNCT01588548
What this trial is testing

Global Phase1 Study to Assess the Safety and Tolerability of AZD1208 in Advanced Solid Tumors and Malignant Lymphoma

Who this might be right for
Advanced Solid MalignanciesMalignant Lymphoma
AstraZeneca 43
Testing effectiveness (Phase 2)Study completedNCT00425191
What this trial is testing

Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer.

Who this might be right for
Non-small Cell Lung Cancer
Sanofi 165
Not applicableStudy completedNCT03283553
What this trial is testing

Involving Family to Improve Communication in Breast Cancer Care

Who this might be right for
Active Breast Cancer Treatment
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 132
Early research (Phase 1)Study completedNCT02635672
What this trial is testing

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Vincerx Pharma, Inc. 110
Testing effectiveness (Phase 2)Ended earlyNCT04750239
What this trial is testing

Safety and Clinical Activity of Nivatrotamab in Relapsed/Recurrent Metastatic Small-cell Lung Cancer

Who this might be right for
SCLC
Y-mAbs Therapeutics 3
Not applicableStudy completedNCT03783481
What this trial is testing

Distress Reduction by Activity Tracking and Activity Enhancement by Mobile Support Group in Oncology

Who this might be right for
Breast CancerMobile Community
Asan Medical Center 202
Large-scale testing (Phase 3)UnknownNCT03391934
What this trial is testing

Comparing Efficacy and Safety of Cetuximab (CinnaGen) Versus Erbitux® (Merck) in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Cinnagen 234
Early research (Phase 1)UnknownNCT05076552
What this trial is testing

Assess the Safety, Pharmacokinetics, and Antitumor Activity of Oral TACH101 in Participants With Advanced or Metastatic Cancer

Who this might be right for
Advanced CancerMetastatic Solid TumorSolid Tumor
Tachyon Therapeutics, Inc. 30
Early research (Phase 1)Looking for participantsNCT06191978
What this trial is testing

A Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
M.D. Anderson Cancer Center 40
Early research (Phase 1)Study completedNCT01967043
What this trial is testing

Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oraxol in Subjects With Advanced Malignancies

Who this might be right for
Solid Tumor
Kinex Pharmaceuticals Inc. 34
Testing effectiveness (Phase 2)Study completedNCT00920140
What this trial is testing

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Who this might be right for
Cancer
GlaxoSmithKline 97
Not applicableLooking for participantsNCT07315347
What this trial is testing

Home Treatment of Patients With Active Cancer and Acute Pulmonary Embolism Without HESTIA Criteria.

Who this might be right for
Active Cancer and Symptomatic or Incidental Pulmonary Embolism Without HESTIA Criteria
Assistance Publique - Hôpitaux de Paris 824
Early research (Phase 1)Study completedNCT01274455
What this trial is testing

Gene Therapy of Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
University Hospital, Toulouse 22
Next Page